FDA Orange Book
Is there a generic for Slynd?
Slynd contains drospirenone. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Slynd (drospirenone). The Orange Book shows its last listed patent expires June 28, 2031.
Run it in Rivvi
Map Slynd and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Slynd products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 4MG | Marketed (Rx) | None | 0 | None |
NDA 211367, held by EXELTIS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Slynd patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10179140 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 12090231 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 9603860 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 10603281 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 11413249 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 10849857 | June 28, 2031 | Drug product | U-2553 | 211367 |
| 11951213 | June 28, 2031 | Method of use | U-2553 | 211367 |
| 11478487 | June 28, 2031 | Drug product | None | 211367 |
| 11504334 | June 28, 2031 | Drug product | None | 211367 |
| 11123299 | June 28, 2031 | Drug product | None | 211367 |
| 10987364 | June 28, 2031 | Drug product | None | 211367 |
| 11291632 | June 28, 2031 | Drug product | None | 211367 |
| 11291633 | June 28, 2031 | Drug product | None | 211367 |
| 12280151 | June 28, 2031 | Drug product | None | 211367 |
| 11351122 | June 28, 2031 | Drug product | None | 211367 |
Questions
Is there a generic for Slynd?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Slynd (drospirenone). The Orange Book shows its last listed patent expires June 28, 2031.
What is the generic name for Slynd?
The active ingredient in Slynd is drospirenone, per the FDA Orange Book.
When does the Slynd patent expire?
The last patent listed for Slynd in the Orange Book expires June 28, 2031. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.